Junbiao Hang
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
-
- Lung Cancer Diagnosis and Treatment 4
- Lung Cancer Treatments and Mutations 2
- Gastric Cancer Management and Outcomes 2
- Surgery 8
- Esophageal Cancer Research and Treatment 3
- Salivary Gland Tumors Diagnosis and Treatment 2
- Esophageal and GI Pathology 2
- Co-authors
- Jiaming Che (9 shared papers)Hecheng Li (15 shared papers)Jie Xiang (4 shared papers)Dingpei Han (9 shared papers)Jie Xiang (7 shared papers)Zhihong Xu (4 shared papers)Jiaan Hu (4 shared papers)Runsen Jin (4 shared papers)
- Journals
- Annals of Translational Medicine (3 papers)BioMed Research International (2 papers)Translational Lung Cancer Research (1 paper)Cancer Biomarkers (1 paper)Diseases of the Esophagus (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Junbiao Hang
27 papers receiving 355 citations
Peers
Comparison fields: 5 of 46
- Cancer Research 69
- Pulmonary and Respiratory Medicine 102
- Surgery 118
- Oncology 48
- Epidemiology 57
Countries citing papers authored by Junbiao Hang
This map shows the geographic impact of Junbiao Hang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junbiao Hang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junbiao Hang more than expected).
Fields of papers citing papers by Junbiao Hang
This network shows the impact of papers produced by Junbiao Hang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junbiao Hang. The network helps show where Junbiao Hang may publish in the future.
Co-authors
The 25 scholars most cited alongside Junbiao Hang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 57 | |
| 2 | MiR-25 is up-regulated in non-small cell lung cancer and promotes cell proliferation and motility by targeting FBXW7. | 2015 | 47 |
| 3 | 2018 | 25 | |
| 4 | 2013 | 24 | |
| 5 | 2023 | 20 | |
| 6 | 2021 | 20 | |
| 7 | 2018 | 19 | |
| 8 | RAF1-MEK1-ERK/AKT axis may confer NSCLC cell lines resistance to erlotinib. | 2013 | 19 |
| 9 | 2018 | 18 | |
| 10 | 2015 | 15 | |
| 11 | 2020 | 15 | |
| 12 | Gefitinib, an EGFR tyrosine kinase inhibitor, activates autophagy through AMPK in human lung cancer cells. | 2014 | 14 |
| 13 | 2017 | 14 | |
| 14 | 2021 | 10 | |
| 15 | 2016 | 7 | |
| 16 | 2017 | 6 | |
| 17 | 2017 | 5 | |
| 18 | 2021 | 4 | |
| 19 | 2019 | 4 | |
| 20 | 2016 | 4 |
About Junbiao Hang
Junbiao Hang is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Molecular Biology, Epidemiology and Pathology and Forensic Medicine, having authored 27 papers that have together received 360 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (4 papers), Esophageal Cancer Research and Treatment (3 papers), Autophagy in Disease and Therapy (3 papers), Salivary Gland Tumors Diagnosis and Treatment (2 papers), Esophageal and GI Pathology (2 papers), Lung Cancer Treatments and Mutations (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Gastric Cancer Management and Outcomes (2 papers). The work is most often cited by research in Cancer Research (69 citations), Pulmonary and Respiratory Medicine (102 citations), Surgery (118 citations), Oncology (48 citations) and Epidemiology (57 citations). Junbiao Hang has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Jiaming Che, Hecheng Li, Jie Xiang, Dingpei Han, Jie Xiang, Zhihong Xu, Jiaan Hu, Runsen Jin, Beili Gao and Yu Han. Their work appears in journals such as Annals of Translational Medicine, BioMed Research International, Translational Lung Cancer Research, Cancer Biomarkers and Diseases of the Esophagus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.